YWP
IMGN

YorkBridge Wealth Partners’s Immunogen Inc IMGN Stock Holding History

YorkBridge Wealth Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,807
Closed -$4K – 696
2019
Q2 		$4K Buy
1,807
+919
+103% +$2.17K ﹤0.01% 677
2019
Q1 		$2K Buy
888
+332
+60% +$1.44K ﹤0.01% 714
2018
Q4 		$3K Buy
556
+45
+9% +$273 ﹤0.01% 668
2018
Q3 		$5K Sell
511
-97
-16% -$932 ﹤0.01% 661
2018
Q2 		$6K Sell
608
-94
-13% -$991 ﹤0.01% 675
2018
Q1 		$7K Sell
702
-48
-6% -$474 ﹤0.01% 660
2017
Q4 		$6K Sell
750
-786
-51% -$4.85K ﹤0.01% 693
2017
Q3 		$12K Sell
1,536
-554
-27% -$3.68K 0.01% 618
2017
Q2 		$14K Sell
2,090
-258
-11% -$1.18K 0.01% 592
2017
Q1 		$10K Sell
2,348
-1,678
-42% -$4.9K 0.01% 623
2016
Q4 		$8K Buy
+4,026
New +$8.08K ﹤0.01% 636

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

YorkBridge Wealth Partners's IMGN Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Immunogen Inc (IMGN) in Q3 2019, closing a stake of 1,807 shares — an estimated $4K sold.

YorkBridge Wealth Partners first reported a position in IMGN in Q4 2016 and held it in 11 quarters. The position peaked at $14K in Q2 2017. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining Immunogen Inc position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 1,807 Immunogen Inc shares in Q3 2019, an estimated $4K.
  • YorkBridge Wealth Partners first reported a position in Immunogen Inc in Q4 2016 and held it in 11 quarters.
  • YorkBridge Wealth Partners's Immunogen Inc position peaked at $14K in Q2 2017.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.